Lexicon Pharmaceuticals, Inc.

LXRX

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001062822

SEC filings (opens in a new tab)

No open-market purchases or sales by Lexicon Pharmaceuticals, Inc. insiders were filed in the last 90 days; 149 institutions reported holding it in 13F filings for Q2 2026, worth $875.1M in total; no superinvestor holds it.

Q3 2024 vs. Q2 2024

How the institutions holding Lexicon Pharmaceuticals, Inc. changed between Q2 2024 and Q3 2024.

All holders in Q3 2024 All holders in Q2 2024

13F holders of LXRX: Q2 2024 compared with Q3 2024
Measure	Q2 2024	Of which not filed for Q3 2024	Q3 2024	Change
Holders	127	2	137	+12
Shares	279.0M	9.91M	288.6M	+19.6M (+7.3%)
Value	$471.0M	$16.6M	$453.1M	−$1.27M (−0.3%)

2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (26)

Institutions that held Lexicon Pharmaceuticals, Inc. at the end of Q3 2024 but not at the end of Q2 2024.

Institutions new to LXRX in Q3 2024
Institution	Shares	Value	% of portfolio
Siren, L.L.C.	38,918,903	$61.1M	3.06%
BlackRock, Inc.	10,133,014	$15.9M	0.00%
Woodline Partners LP	1,211,924	$1.90M	0.02%
Knott David M Jr	500,000	$785.0K	0.31%
Swiss National Bank	317,500	$498.5K	0.00%
Squarepoint Ops LLC	188,842	$296.5K	0.00%
Deerfield Management Company, L.P. (Series C)	156,860	$246.3K	0.00%
UBS Asset Management Americas Inc	120,387	$189.0K	0.00%
Tang Capital Management LLC	100,000	$157.0K	0.01%
XTX Topco Ltd	80,423	$126.3K	0.01%
Atom Investors LP	77,733	$122.0K	0.01%
Intech Investment Management LLC	73,440	$115.3K	0.00%
Acadian Asset Management LLC	58,007	$91.0K	0.00%
Arizona State Retirement System	46,840	$73.5K	0.00%
Great West Life Assurance Co	46,013	$72.0K	0.00%
Teacher Retirement System of Texas	40,800	$64.0K	0.00%
Cetera Investment Advisers	21,775	$34.2K	0.00%
State of Wisconsin Investment Board	12,432	$19.5K	0.00%
Perennial Investment Advisors, LLC	11,600	$18.2K	0.00%
Dynamic Technology Lab Private Ltd	11,338	$18.0K	0.00%
Wolverine Trading, LLC	11,192	$17.9K	0.00%
Legacy Capital Wealth Partners, LLC	10,000	$15.7K	0.00%
Steward Partners Investment Advisory, LLC	400	$628	0.00%
Sterling Capital Management LLC	272	$427	0.00%
Tortoise Investment Management, LLC	21	$33	0.00%
Capital Performance Advisors LLP	18	$28	0.00%

Sold out (14)

Institutions that held Lexicon Pharmaceuticals, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.

Institutions that sold out of LXRX in Q3 2024
Institution	Shares, Q2 2024	Value, Q2 2024
Opaleye Management Inc.	1,875,000	$3.15M
Altium Capital Management LP	121,986	$204.9K
Simplex Trading, LLC	84,637	$142.0K
Great Point Partners LLC	30,000	$50.4K
Tudor Investment Corp Et Al	23,531	$39.5K
Principal Financial Group Inc	22,759	$38.2K
Verition Fund Management LLC	18,158	$30.5K
Coyle Financial Counsel LLC	12,500	$30.0K
CIBC World Markets Inc.	10,980	$18.0K
Smartleaf Asset Management LLC	726	$1.26K
Innealta Capital, LLC	175	$294
Optiver Holding B.V.	155	$260
Comerica Bank	122	$205
Rothschild Investment LLC	75	$126

Not filed for Q3 2024 yet (2)

Institutions that held Lexicon Pharmaceuticals, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding LXRX in Q2 2024 that haven't filed for Q3 2024
Institution	Shares, Q2 2024	Value, Q2 2024
BlackRock Inc.	9,890,153	$16.6M
CVI Holdings, LLC	20,000	$33.6K